Bioscience Company Reports Positive Interim Body Weight Results From Diabetes Study
Lexaria Bioscience Corp. Reports Positive Interim Body Weight Results from Diabetes Animal Study.
Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW), a global innovator in drug delivery platforms, recently announced interim results from the first four weeks of dosing in its ongoing diabetes animal study, WEIGHT-A24-1 (the "Study"). $Lexaria Bioscience (LEXX.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
